Page 28 - Klingenstein Fields News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Klingenstein Fields & Co. LP acquired a new position in Vanguard Dividend Appreciation ETF (NYSEARCA:VIG – Get Rating) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,390 shares of the company’s stock, valued at approximately $211,000. Several other hedge funds have also […]

Klingenstein Fields & Co. LP reduced its holdings in Target Co. (NYSE:TGT – Get Rating) by 24.5% in the 4th quarter, Holdings Channel reports. The fund owned 2,020 shares of the retailer’s stock after selling 655 shares during the period. Klingenstein Fields & Co. LP’s holdings in Target were worth $301,000 as of its most […]

Klingenstein Fields & Co. LP cut its position in shares of Pfizer Inc. (NYSE:PFE – Get Rating) by 2.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 327,354 shares of the biopharmaceutical company’s stock after selling 7,487 shares during the period. Klingenstein Fields & Co. LP’s holdings in Pfizer were worth $16,774,000 as of […]

Klingenstein Fields & Co. LP decreased its stake in shares of Verizon Communications Inc. (NYSE:VZ – Get Rating) by 13.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,289 shares of the cell phone carrier’s stock after selling 1,400 shares during […]

Klingenstein Fields & Co. LP bought a new position in shares of BlackRock, Inc. (NYSE:BLK – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 346 shares of the asset manager’s stock, valued at approximately $245,000. Several other hedge funds also recently made […]